Emergency Use Authorisation
-
{
- All
- News
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
Recommendations On Covaxin Emergency Use For 2-18 Age Group Being Examined: Centre
The Covid Subject Expert Committee's recommendations on granting emergency use authorisation to Bharat Biotech's Covaxin for the 2-18 age group are being examined and additional information has been sought, Rajya Sabha was informed Tuesday.
-
WHO's Emergency Use Authorization For Covaxin "Expected Soon": Health Ministry
The Health Ministry on Friday hinted that the World Health Organization's (WHO) Emergency Use Authorization (EUA) for the COVID-19 vaccine, Covaxin, is expected soon.
-
Pfizer Covid Vaccine Not Recommended For Emergency Use 'At This Stage': Expert Panel
Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage, officials told news agency Press Trust of India on Friday.
-
Pfizer Must Conduct Local Study For Vaccine Approval: Official
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
Seeking More Data For Emergency Use Won't Impact Vaccine Rollout: Centre
The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the centre said on Tuesday, asserting that Drugs Controller General of India (DCGI) seeking more data from these companies will not impact the vaccine-roll out timeline.
-
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Treatment
The United States on Monday withdrew emergency use authorizations for two coronavirus treatments favored by President Donald Trump, citing their lack of efficacy and safety concerns.
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
Recommendations On Covaxin Emergency Use For 2-18 Age Group Being Examined: Centre
The Covid Subject Expert Committee's recommendations on granting emergency use authorisation to Bharat Biotech's Covaxin for the 2-18 age group are being examined and additional information has been sought, Rajya Sabha was informed Tuesday.
-
WHO's Emergency Use Authorization For Covaxin "Expected Soon": Health Ministry
The Health Ministry on Friday hinted that the World Health Organization's (WHO) Emergency Use Authorization (EUA) for the COVID-19 vaccine, Covaxin, is expected soon.
-
Pfizer Covid Vaccine Not Recommended For Emergency Use 'At This Stage': Expert Panel
Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage, officials told news agency Press Trust of India on Friday.
-
Pfizer Must Conduct Local Study For Vaccine Approval: Official
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
Seeking More Data For Emergency Use Won't Impact Vaccine Rollout: Centre
The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the centre said on Tuesday, asserting that Drugs Controller General of India (DCGI) seeking more data from these companies will not impact the vaccine-roll out timeline.
-
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Treatment
The United States on Monday withdrew emergency use authorizations for two coronavirus treatments favored by President Donald Trump, citing their lack of efficacy and safety concerns.
